These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

777 related articles for article (PubMed ID: 20705090)

  • 41. A genetic network model of cellular responses to lithium treatment and cocaine abuse in bipolar disorder.
    McEachin RC; Chen H; Sartor MA; Saccone SF; Keller BJ; Prossin AR; Cavalcoli JD; McInnis MG
    BMC Syst Biol; 2010 Nov; 4():158. PubMed ID: 21092101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder.
    Einat H; Manji HK
    Biol Psychiatry; 2006 Jun; 59(12):1160-71. PubMed ID: 16457783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lithium: bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium.
    Marmol F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1761-71. PubMed ID: 18789369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder.
    Chiu CT; Wang Z; Hunsberger JG; Chuang DM
    Pharmacol Rev; 2013 Jan; 65(1):105-42. PubMed ID: 23300133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lithium-induced neuroprotective activity in neuronal and microglial cells: A purinergic perspective.
    Gubert C; Andrejew R; Figueiro F; Bergamin L; Kapczinski F; Magalhães PVDS; Battastini AMO
    Psychiatry Res; 2021 Jan; 295():113562. PubMed ID: 33213934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lithium and its neuroprotective and neurotrophic effects: potential treatment for post-ischemic stroke sequelae.
    Gold AB; Herrmann N; Lanctôt KL
    Curr Drug Targets; 2011 Feb; 12(2):243-55. PubMed ID: 20863277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroprotective effects of lithium: what are the implications in humans with neurodegenerative disorders?
    Morlet É; Hozer F; Costemale-Lacoste JF
    Geriatr Psychol Neuropsychiatr Vieil; 2018 Mar; 16(1):78-86. PubMed ID: 29400298
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The lithium ion: a foundation for psychopharmacological specificity.
    Soares JC; Gershon S
    Neuropsychopharmacology; 1998 Sep; 19(3):167-82. PubMed ID: 9653704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular mechanisms and therapeutic potential of lithium in Alzheimer's disease: repurposing an old class of drugs.
    Shen Y; Zhao M; Zhao P; Meng L; Zhang Y; Zhang G; Taishi Y; Sun L
    Front Pharmacol; 2024; 15():1408462. PubMed ID: 39055498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?
    Manji HK; Moore GJ; Chen G
    Biol Psychiatry; 1999 Oct; 46(7):929-40. PubMed ID: 10509176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiviral, immunomodulatory, and neuroprotective effect of lithium.
    Rybakowski JK
    J Integr Neurosci; 2022 Mar; 21(2):68. PubMed ID: 35364656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The role of lithium in neurodegenerative diseases: new registries for old actors].
    Pérez-Martínez DA
    Neurologia; 2009 Apr; 24(3):143-6. PubMed ID: 19418288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vitis labrusca extract effects on cellular dynamics and redox modulations in a SH-SY5Y neuronal cell model: a similar role to lithium.
    Scola G; Laliberte VL; Kim HK; Pinguelo A; Salvador M; Young LT; Andreazza AC
    Neurochem Int; 2014 Dec; 79():12-9. PubMed ID: 25445986
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inositol, lithium, and the brain.
    Agranoff BW; Fisher SK
    Psychopharmacol Bull; 2001; 35(3):5-18. PubMed ID: 12397875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lithium-related genetics of bipolar disorder.
    Detera-Wadleigh SD
    Ann Med; 2001 May; 33(4):272-85. PubMed ID: 11405549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of microtubule actin crosslinking factor 1 (MACF1) in bipolar disorder pathophysiology and potential in lithium therapeutic mechanism.
    Salem D; Fecek RJ
    Transl Psychiatry; 2023 Jun; 13(1):221. PubMed ID: 37353479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?
    Moore GJ; Bebchuk JM; Hasanat K; Chen G; Seraji-Bozorgzad N; Wilds IB; Faulk MW; Koch S; Glitz DA; Jolkovsky L; Manji HK
    Biol Psychiatry; 2000 Jul; 48(1):1-8. PubMed ID: 10913502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.
    Gray NA; Zhou R; Du J; Moore GJ; Manji HK
    J Clin Psychiatry; 2003; 64 Suppl 5():3-17. PubMed ID: 12720479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lithium therapy in the treatment of manic-depressive illness. Present status and future perspectives. A critical review.
    Emilien G; Maloteaux JM; Seghers A; Charles G
    Arch Int Pharmacodyn Ther; 1995; 330(3):251-78. PubMed ID: 8836446
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploring lithium's transcriptional mechanisms of action in bipolar disorder: a multi-step study.
    Akkouh IA; Skrede S; Holmgren A; Ersland KM; Hansson L; Bahrami S; Andreassen OA; Steen VM; Djurovic S; Hughes T
    Neuropsychopharmacology; 2020 May; 45(6):947-955. PubMed ID: 31652432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.